LATEST NEWS
Bridging Global Innovations in Precision Medicine
We have built a closed-loop commercialization platform to
translate technological advances into healthcare
solutions that improve patient care.

Digital Pathology Biomarkers
A.I. based software solutions for cancer tissue pathology

Digital Pathology Slide Scanner
MBMbio-intelligence digital pathology slide scanner designed for A.I.

Novel RBC Liquid Biopsy
A novel red blood cell (RBC) based liquid biopsy platform for cancers

Clinical Research Lab
CAP and CLIA ready clincal
laboratory

Digital Pathology Software
A.I.-based software solutions
for cancer tissue pathology
analysis

MBMbio- intelligence
Made for A.I. digital
pathology scanner

Novel Red Blood Cell Liquid
Biopsy
Liquid biopsy platform for
early stage cancer monitoring

Clinical Research Lab
CAP and CLIA ready clincal
laboratory
Our Story
Our work begins with a passion for global innovations that can positively impact clinical practice
Our Impact
Advancing Cancer Care
Through Precision
Medicine.
Our technology solutions include precision medicine products and
services that are designed to improve the quality of cancer care.
- Digital Pathology Software
- MBMbio-Intelligence
- Novel Red Blood Cell Liquid Biopsy
- Clinical Research Lab Services
Partnerships
Building a Stronger, Healthier
Future Together
Solving problems in cancer treatment is a complicated job. At MBM, we believe this challenge is best solved through a network and foundation of strategic partnerships.
Latest Blog Posts
News and healthcare tips
Identification of Early Cancer through Peripheral Blood Mature Red Blood Cells! Chinese Scholars Reveal Cancer-Related Large DNA Fragments within Red Blood Cells for the First Time
Identification of Early Cancer through Peripheral Blood Mature Red Blood Cells! Chinese Scholars Reveal Cancer-Related Large DNA...
MBMbio announced residency at JLABS @ Shanghai
MBMbio announced residency at JLABS @ ShanghaiDecember 1, 2021Shanghai China, December 1, 2021 – MBMbio announced today that, effective...
Red Blood Cells Offer a Breakthrough in Liquid Biopsy Technology
The Often Neglected Red Blood Cell Offers a Breakthrough in Liquid Biopsy Technology for Early Stage Cancer Detection
Colorectal Cancer Recurrence Risk Assessment Marker Announcement
MBM’s “Colorectal Cancer Recurrence Risk Assessment Marker” announced at the National Colorectal Surgery Symposium
It all starts with a pursuit to transform cancer patient care.